Infosys Ltd
NYSE:INFY
Infosys Ltd
NYSE:INFY
Price:
22.73
USD
-2.95%
Market Closed
Market Cap:
94.4B
USD
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
INFY Alert
Infosys Ltd
22.73
-0.69 (-2.95%)
| 52 Week Range |
16.51
23.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Infosys Ltd
Balance Sheet
Balance Sheet Decomposition
Infosys Ltd
Infosys Ltd
| Current Assets | 895.3B |
| Cash & Short-Term Investments | 300.5B |
| Receivables | 523.2B |
| Other Current Assets | 71.5B |
| Non-Current Assets | 523.4B |
| Long-Term Investments | 111.8B |
| PP&E | 191.5B |
| Intangibles | 134.5B |
| Other Non-Current Assets | 85.6B |
| Current Liabilities | 408.3B |
| Accounts Payable | 38.4B |
| Accrued Liabilities | 161.9B |
| Other Current Liabilities | 208B |
| Non-Current Liabilities | 105.8B |
| Long-Term Debt | 63.6B |
| Other Non-Current Liabilities | 42.2B |
Balance Sheet
Infosys Ltd
Infosys Ltd
Currency: INR
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
258 310
|
269 280
|
143 170
|
126 350
|
138 390
|
118 920
|
195 650
|
134 710
|
96 640
|
147 860
|
|
| Cash Equivalents |
258 310
|
269 280
|
143 170
|
126 350
|
138 390
|
118 920
|
195 650
|
134 710
|
96 640
|
147 860
|
|
| Short-Term Investments |
50 460
|
53 520
|
177 060
|
130 570
|
119 980
|
110 160
|
69 870
|
104 740
|
93 110
|
138 400
|
|
| Total Receivables |
145 400
|
171 650
|
187 040
|
194 400
|
232 620
|
279 190
|
296 970
|
374 390
|
452 800
|
538 690
|
|
| Accounts Receivables |
125 580
|
143 590
|
159 700
|
174 030
|
202 010
|
256 080
|
268 210
|
348 210
|
414 030
|
434 980
|
|
| Other Receivables |
19 820
|
28 060
|
27 340
|
20 370
|
30 610
|
23 110
|
28 760
|
26 180
|
38 770
|
103 710
|
|
| Inventory |
790
|
1 100
|
1 310
|
1 190
|
1 090
|
1 450
|
1 410
|
0
|
0
|
3 560
|
|
| Other Current Assets |
17 000
|
21 400
|
28 470
|
47 660
|
36 700
|
36 040
|
43 430
|
58 010
|
66 260
|
69 290
|
|
| Total Current Assets |
471 960
|
516 950
|
537 050
|
500 170
|
528 780
|
545 760
|
607 330
|
671 850
|
708 810
|
894 320
|
|
| PP&E Net |
91 250
|
105 300
|
117 160
|
121 430
|
133 560
|
178 670
|
184 170
|
183 140
|
205 160
|
192 150
|
|
| PP&E Gross |
91 250
|
105 300
|
117 160
|
121 430
|
133 560
|
178 670
|
184 170
|
183 140
|
205 160
|
192 150
|
|
| Accumulated Depreciation |
64 220
|
74 510
|
85 810
|
100 630
|
114 120
|
132 060
|
150 910
|
163 000
|
167 430
|
182 170
|
|
| Intangible Assets |
6 380
|
9 850
|
7 760
|
2 470
|
6 910
|
19 000
|
20 720
|
17 070
|
17 490
|
13 970
|
|
| Goodwill |
30 910
|
37 640
|
36 520
|
22 110
|
35 400
|
52 860
|
60 790
|
61 950
|
72 480
|
73 030
|
|
| Note Receivable |
41 200
|
52 550
|
57 450
|
75 340
|
73 200
|
62 320
|
71 910
|
80 690
|
90 890
|
56 900
|
|
| Long-Term Investments |
14 380
|
19 140
|
64 530
|
57 560
|
46 340
|
41 370
|
118 630
|
138 280
|
134 940
|
128 270
|
|
| Other Long-Term Assets |
7 440
|
12 460
|
13 080
|
19 820
|
23 190
|
27 700
|
20 310
|
25 870
|
28 390
|
19 500
|
|
| Other Assets |
30 910
|
37 640
|
36 520
|
22 110
|
35 400
|
52 860
|
60 790
|
61 950
|
72 480
|
73 030
|
|
| Total Assets |
663 520
N/A
|
753 890
+14%
|
833 550
+11%
|
798 900
-4%
|
847 380
+6%
|
927 680
+9%
|
1 083 860
+17%
|
1 178 850
+9%
|
1 258 160
+7%
|
1 378 140
+10%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1 400
|
3 860
|
3 670
|
6 940
|
16 550
|
28 520
|
26 450
|
41 340
|
38 650
|
39 560
|
|
| Accrued Liabilities |
51 660
|
57 960
|
58 260
|
63 820
|
75 120
|
87 780
|
105 200
|
137 190
|
143 750
|
153 000
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
6 190
|
7 380
|
8 720
|
12 420
|
19 590
|
|
| Other Current Liabilities |
60 770
|
70 570
|
78 200
|
70 290
|
94 710
|
86 070
|
99 620
|
148 780
|
197 040
|
175 790
|
|
| Total Current Liabilities |
113 830
|
132 390
|
140 130
|
141 050
|
186 380
|
208 560
|
238 650
|
336 030
|
391 860
|
387 940
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
40 140
|
45 870
|
46 020
|
70 570
|
64 000
|
|
| Deferred Income Tax |
1 600
|
2 560
|
2 070
|
5 410
|
6 720
|
9 680
|
8 750
|
11 560
|
12 200
|
17 940
|
|
| Minority Interest |
0
|
0
|
0
|
10
|
580
|
3 940
|
4 310
|
3 860
|
3 880
|
3 450
|
|
| Other Liabilities |
460
|
1 150
|
1 530
|
3 200
|
4 220
|
10 860
|
22 770
|
27 880
|
25 580
|
23 650
|
|
| Total Liabilities |
115 890
N/A
|
136 100
+17%
|
143 730
+6%
|
149 670
+4%
|
197 900
+32%
|
273 180
+38%
|
320 350
+17%
|
425 350
+33%
|
504 090
+19%
|
496 980
-1%
|
|
| Equity | |||||||||||
| Common Stock |
5 720
|
11 440
|
11 440
|
10 880
|
21 700
|
21 220
|
21 240
|
20 980
|
20 690
|
20 710
|
|
| Retained Earnings |
509 780
|
576 550
|
650 560
|
628 800
|
614 790
|
616 870
|
718 930
|
717 820
|
713 920
|
831 470
|
|
| Additional Paid In Capital |
28 060
|
22 410
|
23 560
|
1 860
|
3 960
|
6 000
|
9 930
|
2 000
|
1 660
|
6 160
|
|
| Other Equity |
4 070
|
7 390
|
4 260
|
7 690
|
9 030
|
10 410
|
13 410
|
12 700
|
17 800
|
22 820
|
|
| Total Equity |
547 630
N/A
|
617 790
+13%
|
689 820
+12%
|
649 230
-6%
|
649 480
+0%
|
654 500
+1%
|
763 510
+17%
|
753 500
-1%
|
754 070
+0%
|
881 160
+17%
|
|
| Total Liabilities & Equity |
663 520
N/A
|
753 890
+14%
|
833 550
+11%
|
798 900
-4%
|
847 380
+6%
|
927 680
+9%
|
1 083 860
+17%
|
1 178 850
+9%
|
1 258 160
+7%
|
1 378 140
+10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
4 571
|
4 571
|
4 571
|
4 347
|
4 336
|
4 241
|
4 245
|
4 193
|
4 136
|
4 140
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
